CTRI/2023/03/050348招募中2 期
A randomized, double-blind, placebo-controlled trial of individualized homoeopathic medicines in addition to standard care in chronic periodontitis in adults
D N De Homoeopathic Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with chronic periodontitis, as diagnosed by the periodontitis screening and recording (PSR) (ICD10 code: K05.30), symptoms persisting for 3 months or more, as assessed by:
- •a) Gingival plaque (score up to 3)
- •b) Altered gingival margins (rolled, flattened, recessions)
- •c) Bleeding on probing (BOP; score up to 3)
- •d) Periodontal probing depth (PPD; up to 4-5.5mm)
- •e) Clinical attachment loss (CAL; moderate 3 to 4 mm)
- •2. Patients having at least 22 teeth present
- •3. Age 18 to 65 years
- •3. Participants of either sex
- •4. Literate: ability to read English, Hindi and/or Bengali (Illiterate people will be interviewed by the investigators maintaining adequate privacy to fill up the questionnaires).
- •5. Providing with written informed consent voluntarily
排除标准
- •1. Severe form of chronic periodontitis (more than 5 mm CAL) or aggressive periodontitis
- •2. Patients who have undergone nonsurgical periodontal treatment (NSPT) within 6 months.
- •3. Antibiotics and steroids therapy for periodontitis or gingivitis or any other similar conditions in the last month
- •4. Patients having orthodontic appliances
- •5. Cases having severe oral inflammation unrelated to periodontal conditions
- •6. Cases requiring immediate tooth extraction
- •7. Vulnerable population - unconscious, non-ambulatory, differently abled, terminally ill or critically ill patients, mentally incompetent people.
- •8. Diagnosed cases of unstable mental or psychiatric illness, infectious disease (e.g., tuberculosis) or other uncontrolled or life-threatening illness affecting quality of life or any organ failure
- •9. Tobacco chewing and/or smocking, alcoholism, and/or any other form(s) of substance
- •10. Self-reported immune-compromised state e.g., HIV
- •11. Pregnant and puerperal women, lactating mothers
- •12. Undergoing homoeopathic treatment for chronic disease within the last 6 months.
- •13. Simultaneously participations in any other clinical trials.
研究者
相似试验
进行中（未招募）
不适用
Efficacy and safety study of DEB025/Alisporivir combined to Peg-IFN and Ribavirin in chronic hepatitis C genotype 1 naïve patients.Chronic Hepatitis C genotype 1 treatment-naïve patientsMedDRA version: 14.1Level: LLTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsEUCTR2010-022867-37-DEovartis Pharma Services AG1,040
招募中
1 期
A randomized, double-blind, placebo-controlled trial of Qidong Bufei Decoction in treating postoperative symptoms of non-small cell lung cancernon-small cell lung cancerITMCTR2100004896Guang'anmen Hospital, China Academy of Chinese Medical Sciences.
尚未招募
2 期
The effect of Morus nigra extract on patients with liver cirrhosisiver cirrhosis.Fibrosis and cirrhosis of liverIRCT20140301016776N3Mashhad University of Medical Sciences80
招募中
4 期
A randomized, double-blind, placebo-controlled clinical trial of Shugan Jieyu Capsule on improving sleep disturbance in New Coronavirus pneumonia during convalescencePatients with sleep mood disorders during recovery from new coronavirus pneumoniaITMCTR2100004389Hubei Hospital of Traditional Chinese Medicine
已完成
不适用
Effects of eating high-protein oral nutrition supplement (Nucare Active) improving muscle functioDiseases of the nervous systemKCT0007708DAESANG Life Science Corporation70